Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ASND Ascendis Pharma A/S - Ordinary Share | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $236.72 -1.0% | $15.06 -2.0% |
| StockIQ Score | 46D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 36F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 74B | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Ascendis Pharma (ASND) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (80 vs. 37) and technical score (78 vs. 18) are significantly higher, while AAPG’s rating is "WEAK" compared to ASND’s "STRONG." Only AAPG’s growth score (50) exceeds ASND’s unavailable data, but the other metrics clearly favor ASND.